Ahead of Thursday’s landmark Nasdaq listing for Claude developer Anthropic (NASDAQ: ANT)—targeting a valuation of up to $1.4 trillion—Wall Street banks, ETF issuers, and global retail platforms are rolling out leveraged products, VIP roadshows, and livestreams, even as hyperscalers and broader AI equities face a steep pullback.
📌 Retail Demand & Leveraged ETF Wave:
• $250M Projected Day-One Retail Buying: Vanda Research forecasts Anthropic will attract ~$250 million in net retail buying on debut—more than double the record $118 million seen during SpaceX’s June IPO (which priced at $135, spiked to $225, dipped to $104, and now trades near $142).
• 11 Leveraged Single-Stock ETFs: Regulatory filings point to at least 11 leveraged single-stock ETFs launching across seven issuers, including 2x bull and 2x bear ETFs from GraniteShares, a 2X Long Daily ETF from Tradr, and a leveraged covered-call ETF in Canada from Ninepoint Partners—with analysts noting recent crypto selling partly reflects retail traders raising cash for the listing.
• Wall Street Roadshows & Perks: Goldman Sachs hosted a wealth-client launch event featuring President John Waldron, Anthropic CFO Krishna Rao, and Co-Founder Daniela Amodei, while JPMorgan hosted CEO Dario Amodei for investor meetings and plans an IPO livestream with branded merchandise.
📌 Valuation Skepticism & Retail Access Divide:
• Institutional Caution: Long-only manager Orbis Global Equity Strategy stated it will sit out the IPO, calling a ~$1.4T–$1.5T price tag expensive for an unproven business model.
• Mixed Retail Conviction: Despite an “extremely bullish” 85/100 sentiment score on StockTwits, 67% of over 18,000 polled members said they will not buy at the IPO (only 20% plan to buy; 13% will wait on pricing).
• Pre-IPO Allocation Gap: While international platforms like Robinhood UK are channeling overseas retail orders, strategists warn that retail buyers risk paying steep day-one entry multiples after institutional insiders capture pre-IPO gains.
💡 Market Takeaway: Anthropic’s public debut is the ultimate litmus test for AI application monetization. While Wall Street’s product machine and retail enthusiasm remain in overdrive, disciplined institutional investors are drawing a sharp line between frontier AI excitement and valuation reality.
